Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Early preeclampsia test could save thousands of newborns and moms

NCT ID NCT05521776

Prevention Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a simple screening test in early pregnancy (around 11-14 weeks) can predict and help prevent preeclampsia, a dangerous condition involving high blood pressure. The trial will involve 14,500 pregnant women and aims to reduce severe complications like premature birth or low birth weight. If successful, this screening could become a routine part of prenatal care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 14,500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2023

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria : * Pregnancy between 11 and 14 WG * Age ≥18 years * Affiliated to or beneficiary of a health insurance system (including AME) * Signed informed consent Exclusion Criteria : * Gestational age \<11 WG or \>14 WG * Known ectopic pregnancy * Known non-ongoing pregnancy * Known multiple pregnancy * History of PE in a previous pregnancy * Pregnancies complicated by major fetal abnormality identified at the first-trimester ultrasound if performed before randomization * Absence of health insurance * Contra-indication to aspirin (bleeding disorders such as von Willebrand's disease, active peptic ulceration, hypersensitivity to aspirin, active peptic ulceration, NSAID-exacerbated respiratory disease, severe liver or heart dysfunction) * Women taking low-dose aspirin regularly and started before pregnancy (except ART indication) * Age \<18 years * Poor understanding of the French language

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Preeclampsia (PE) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

preeclampsia prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Preeclampsia (PE)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    22 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHI de Poissy

    RECRUITING

    Poissy, France

  • CHRU de Nancy

    RECRUITING

    Nancy, France

  • CHU Angers

    RECRUITING

    Angers, France

  • CHU Charles Nicolle

    RECRUITING

    Rouen, France

  • CHU Dijon Bourgogne

    RECRUITING

    Dijon, France

  • CHU Estaing

    RECRUITING

    Clermont-Ferrand, France

  • CHU Lille

    RECRUITING

    Lille, France

  • CHU Strasbourg, CMCO Schiltigheim

    RECRUITING

    Strasbourg, France

  • CHU de Bordeaux

    RECRUITING

    Bordeaux, France

  • Hôpital Antoine Béclère

    RECRUITING

    Clamart, France

  • Hôpital Armand Trousseau

    RECRUITING

    Paris, France

  • Hôpital Bretonneau

    RECRUITING

    Tours, France

  • Hôpital Cochin (site Port-Royal)

    RECRUITING

    Paris, France

  • Hôpital Femme - Maternité

    RECRUITING

    Nantes, France

  • Hôpital Femme Mère Enfant

    RECRUITING

    Bron, France

  • Hôpital Intercommunal Créteil

    RECRUITING

    Créteil, France

  • Hôpital Nord

    RECRUITING

    Marseille, France

  • Hôpital Paule de Viguier

    RECRUITING

    Toulouse, France

  • Hôpital Saint-Joseph

    RECRUITING

    Paris, France

  • Hôpital Sud Rennes

    RECRUITING

    Rennes, France

  • Hôpital de Hautepierre

    RECRUITING

    Strasbourg, France

  • Hôpital de la conception et de la Timone

    RECRUITING

    Marseille, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.